Poster Presentations: Posters Saturday, 16 April 2016: Viral hepatitis: Hepatitis C – Clinical (therapy)| Volume 64, ISSUE 2, SUPPLEMENT , S749, January 01, 2016

Reasons for Denial of Directly Acting Antivirals (DAA’S) for Chronic Hepatitis C in a United States Treatment Cohort

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment
      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect